Brian Bergmark, MD, FACC

Brian Bergmark

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Janssen Pharmaceuticals, Inc(SIGNIFICANT), Quark Pharmaceuticals(MODEST), Abbott Vascular(SIGNIFICANT), Philips(MODEST), Servier(SIGNIFICANT), CSI(MODEST), Abiomed(SIGNIFICANT), Endovascular Engineering(SIGNIFICANT), SpectraWAVE(MODEST), Terumo(MODEST), Bain Life Sciences(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: AstraZeneca Pharmaceuticals(NONE), Pfizer Inc(NONE), Ionis(NONE), Abbott Laboratories(NONE), Microport(NONE)

View Full Disclosure